GSK

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 15 Jun 2015
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

1,875,000€

Financial year: Jan 2014 - Dec 2014

Lobbyists (Full time equivalent)

5 Fte (11)

Lobbyists with EP accreditation

6

High-level Commission meetings

12

Lobbying Costs over the years

  • Info

    GlaxoSmithKline   (GSK)

    EU Transparency Register

    7990322925-77 First registered on 06 Jan 2009

    Goals / Remit

    GSK is a science-led global healthcare company.

    Our mission is to help people do more, feel better, live longer.


    We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare that can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute to the prosperity of their communities.

    Our Pharmaceuticals business develops and makes medicines to treat a broad range of acute and chronic diseases. Our portfolio is made up of both patent-protected and off patent medicines and we have leading global positions in respiratory disease and HIV.

    Our Vaccines business is one of the largest in the world. We have a broad portfolio of over 30 paediatric, adolescent, adult and travel vaccines. In 2014, we distributed approximately 800 million doses in 170 countries.

    We develop and market a range of consumer healthcare products based on scientific innovation. We have brands in four main categories: Wellness, Oral Health, Skin Health and Nutrition. These include a number of well-known brands such as Sensodyne, Panadol and Horlicks.


    We have a significant global presence with commercial operations in more than 150 countries, a network of 84 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China.

    Main EU files targeted

    We follow EU initiatives, policies and legislative files related to our Pharmaceuticals, Vaccines and Consumer Healthcare businesses.

    This includes topics such as R&D and clinical trials, antimicrobial resistance, data protection, pharmaceutical legislation, medical devices, trade & IP, environment, smoking cessation.

    Address

    Head Office
    Great West Road, 980
    Brentford, Middlesex TW8 9GS
    UNITED KINGDOM
    EU Office
    Avenue des Arts 46/b9
    Brussels 1000
    BELGIUM
  • People

    Total lobbyists declared

    11

    Employment timeLobbyists
    75%3
    50%3
    25%5

    Lobbyists (Full time equivalent)

    5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    6 accreditations were / are live (in bold) for the selected state of 15 Jun 2015

    Name Start date End Date
    Mr Bonifac Abel MAKKAI 20 Mar 2024 02 Oct 2024
    Ms Gisela Payeras Bailly 20 Mar 2024 02 Oct 2024
    Mr Alberto Giummarra 12 Mar 2024 11 Mar 2025
    Ms Sofia BENITO KWIECINSKI 20 Feb 2024 19 Feb 2025
    Mr Alberto Giummarra 18 Mar 2023 12 Mar 2024
    Ms Renatte Georgescu 17 Mar 2023 16 Mar 2024
    Ms Sofia BENITO KWIECINSKI 22 Feb 2023 20 Feb 2024
    Ms Chloe CROSS 02 Aug 2022 02 Aug 2023
    Ms Gisela Payeras Bailly 09 Apr 2022 08 Apr 2023
    Mr Alberto Giummarra 01 Apr 2022 18 Mar 2023
    Ms Renatte Georgescu 01 Apr 2022 17 Mar 2023
    Ms Chloe CROSS 15 Apr 2021 15 Apr 2022
    Ms Gisela Payeras Bailly 15 Apr 2021 09 Apr 2022
    Mr Alberto Giummarra 07 Apr 2021 01 Apr 2022
    Ms Renatte Georgescu 07 Apr 2021 01 Apr 2022
    Mihaela ALIONTE 22 Feb 2020 20 Feb 2021
    Mr Alberto Giummarra 22 Feb 2020 20 Feb 2021
    Ms Renatte Georgescu 08 Feb 2020 06 Feb 2021
    Ms Katja Murray 25 Jan 2020 01 Feb 2021
    Ms Valentina Laurenzia Ancona 25 Jan 2020 01 Feb 2021
    Ms Gisela Payeras Bailly 08 Nov 2019 07 Nov 2020
    Ms Georgia Catherine JANE CASSARINO 17 Oct 2019 17 Oct 2020
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 05 Sep 2019 05 Sep 2020
    Mr Christian Baracat 05 Sep 2019 18 Oct 2019
    Mr Paulus Lambertus Antonius van Hoof 17 Aug 2019 15 Aug 2020
    Ms Renatte Georgescu 02 Feb 2019 08 Feb 2020
    Ms Gisela Payeras Bailly 31 Oct 2018 31 Oct 2019
    Ms Georgia Catherine JANE CASSARINO 26 Oct 2018 17 Oct 2019
    Mr Christian Baracat 05 Sep 2018 05 Sep 2019
    Mr Paulus Lambertus Antonius van Hoof 07 Aug 2018 07 Aug 2019
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 19 Jun 2018 19 Jun 2019
    Ms Gisela Payeras Bailly 27 Oct 2017 26 Oct 2018
    Ms Georgia Catherine JANE CASSARINO 27 Oct 2017 25 Oct 2018
    Mr Christian Baracat 31 Aug 2017 17 Aug 2018
    Mr Paulus Lambertus Antonius van Hoof 31 Aug 2017 07 Aug 2018
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 10 Oct 2016 07 Oct 2017
    Ms Gisela Payeras Bailly 05 Sep 2016 31 Aug 2017
    Mr Christian Baracat 22 Aug 2016 02 Aug 2017
    Mr Paulus Lambertus Antonius van Hoof 22 Aug 2016 02 Aug 2017
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 26 Sep 2015 25 Sep 2016
    Ms Karin Jeanette Drielsma 22 Sep 2015 31 Jan 2016
    Mr Christian Baracat 29 Aug 2015 23 Aug 2016
    Ms Gisela Payeras Bailly 29 Aug 2015 28 Aug 2016
    Mr Paulus Lambertus Antonius van Hoof 31 Jul 2015 29 Jul 2016
    Ms Karin Jeanette Drielsma 06 Aug 2014 04 Aug 2015
    Ms Sophie Renee Jeanne Marie Philippine Crousse 03 Sep 2014 28 Aug 2015
    Ms Gisela Payeras Bailly 26 Aug 2014 19 Aug 2015
    Mr Nicholas Collinge Crosby 08 Oct 2014 03 Jun 2015
    Ms Diana Mereu 04 Oct 2014 03 Jun 2015
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 30 Sep 2014 26 Sep 2015
    Mrs Sophie Renee Jeanne Marie Philippine Crousse 03 Sep 2014 27 Jan 2015
    Mr Christian Baracat 26 Aug 2014 19 Aug 2015
    Mrs Gisela Payeras Bailly 26 Aug 2014 27 Jan 2015
    Mrs Karin Jeanette Drielsma 06 Aug 2014 27 Jan 2015
    Mr Paulus Lambertus Antonius van Hoof 02 Aug 2014 31 Jul 2015
    Mr Guilherme Monteiro Ferreira Borges Dos Santos 28 Sep 2013 27 Sep 2014
    Mrs Elisaveta Voynova 28 Sep 2013 27 Sep 2014
    Mr Paulus Lambertus Antonius van Hoof 25 Jul 2013 24 Jul 2014
    Mrs Gisela Payeras Bailly 25 Jul 2013 24 Jul 2014
    Mr Christopher Black 23 Jul 2013 20 Jul 2014
    Mr Johan Christoffer Thor 23 Jul 2013 20 Jul 2014
    Mrs Karin Jeanette Drielsma 23 Jul 2013 20 Jul 2014
    Mrs Sophie Renee Jeanne Marie Philippine Crousse 23 Jul 2013 20 Jul 2014
    Mr Philippe GHYSSELS 17 Jan 2012 08 Feb 2013

    Complementary Information

    The number of persons reflects the full time employment falling under the scope of the register. GSK follows the guidelines provided by EFPIA regarding this registration.

    Person in charge of EU relations

    Ms Sue Middleton (Vice President European Government Affairs)

    Person with legal responsibility

    Mr Andrew Witty (Chief Executive Officer)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    American Chamber of Commerce to the European Union (AmChamEU)
    Association of the European Self-Medication Industry (AESGP)
    British Chamber of Commerce in Belgium
    Cosmetics Europe
    EuropaBio
    European Biopharmaceutical Enterprises (EBE)
    European Brands Association (AIM)
    European Diagnostic Manufacturers Association (EDMA)
    European Federation of Pharmaceutical Industries and Associations (EFPIA)
    Vaccines Europe (VE)
    World Federation of Advertisers (WFA)

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2014 - Dec 2014

    Lobbying costs for closed financial year

    1,875,000€

    EU grant income for closed financial year

    10,445,466 € (Source: FP7-People; FP7-NMP; Horizon 2020)

    Other financial info

    In 2013, GSK’s estimated costs attributable to activities covered by the Register were in the range of 600.000-700.000. While GSK maintained activities in scope of the register from 2013 to 2014, the increased figures result from vacancies and the renewed “transparency register implementing guidelines” published 21 January 2015 by the Joint Transparency Register Secretariat.
    GSK followed EFPIA’s interpretation and guidance on implementing those guidelines in 2014.

  • EU Structures

    Groups (European Commission)

    EC Expert Group on Rare-Diseases (on behalf of EuropaBio)

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    Mainly via the participation of events organized by Trade Associations and Think-Tanks.

    Other activities

    None declared

  • Meetings

    Meetings

    12 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 28 Apr 2021 Location Brussels
      Subject EU vaccine production and pandemic preparedness
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Maurits-Jan Prinz (Cabinet member)
    • Date 11 Feb 2021 Location webex
      Subject vaccines
      DG Health and Food Safety
      Attending
      • Sandra Gallina (Director-General)
    • Date 31 May 2018 Location Brussels
      Subject Brexit preparedness
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
    • Date 23 Mar 2018 Location Brussels
      Subject IP regime generic manufacturers in the pharmaceutical industry
      Cabinet Cabinet of Commissioner Pierre Moscovici
      Portfolio Economic and Financial Affairs, Taxation and Customs
      Attending
      • Leila Fernandez-Stembridge (Cabinet member)
    • Date 01 Dec 2017 Location Brussels
      Subject FTA implementation & transparency / trade relations with China, Turkey, Russia / importance of including vaccines in trade negotiations
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Nele Eichhorn (Cabinet member)
      • Maria Asenius (Cabinet member)
    • Date 09 Nov 2017 Location Brussels
      Subject Innovation in the pharmaceutical sector, SPC, health technology assessments
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Marika Lautso-Mousnier (Cabinet member)
    • Date 26 Jun 2017 Location Brussels
      Subject Antimicrobial resistance (AMR)
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Carlos Moedas (Commissioner)
    • Date 30 Sep 2015 Location Brussels
      Subject Vaccination
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Paula Duarte Gaspar (Cabinet member)
    • Date 24 Sep 2015 Location Brussels
      Subject Challenges of the pharma industry
      Cabinet Cabinet of Commissioner Carlos Moedas
      Portfolio Research, Science and Innovation
      Attending
      • Carlos Moedas (Commissioner)
    • Date 18 May 2015 Location Brussels
      Subject Access to medicines in Africa
      Cabinet Cabinet of Vice-President Cecilia Malmström
      Portfolio Trade
      Attending
      • Cécile Billaux (Cabinet member)
    • Date 16 Jan 2015 Location PRAGUE, CZECH REPUBLIC
      Subject Round Table on Gender Diversity
      Cabinet Cabinet of Commissioner Věra Jourová
      Portfolio Justice, Consumers and Gender Equality
      Attending
      • Věra Jourová (Commissioner)
      Other Lobbyists
    • Date 05 Dec 2014 Location Brussels
      Subject Life sciences contribution to growth and jobs
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Aura Salla (Cabinet member)
      • Heidi Jern (Cabinet member)
Download this datacard